Stanley Druckenmiller’s Zimmer Biomet ZBH Stock Holding History

Stanley Druckenmiller’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-125,815	Closed	-$14.6M	–	82
2020 Q2	$14.6M	Buy	+125,815	New	+$14.5M	0.45%	44

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Stanley Druckenmiller's ZBH Position: Q3 2020 in Review

Stanley Druckenmiller sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 125,815 shares — an estimated $14.6M sold.

Stanley Druckenmiller first reported a position in ZBH in Q2 2020 and held it in 1 quarter. The position peaked at $14.6M in Q2 2020. 931 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

Stanley Druckenmiller reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
Stanley Druckenmiller sold 125,815 Zimmer Biomet shares in Q3 2020, an estimated $14.6M.
Stanley Druckenmiller first reported a position in Zimmer Biomet in Q2 2020 and held it in 1 quarter.
Stanley Druckenmiller's Zimmer Biomet position peaked at $14.6M in Q2 2020.
931 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Duquesne Family Office's 13F filing for Q3 2020, filed 16 Nov 2020.